• 1
    Zuberbier T. Urticaria. Allergy 2003;58: 12241234.
  • 2
    Niimi N, Francis DM, Kermani F, O'Donnell BF, Hide M, Kobza-Black A et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996;106: 10011006.
  • 3
    Sabroe RA, Greaves MW. The pathogenesis of chronic idiopathic urticaria. Arch Dermatol 1997;133: 10031008.
  • 4
    Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993;328: 15991604.
  • 5
    O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997;136: 197201.
  • 6
    Bindslev-Lensen C, Finzi A, Greaves M, Camarasa J, Ortonne JP, Schopf E et al. Chronic urticaria: diagnostic recommendations. J Eur Acad Dermatol Venereol 2000;14: 175180.
  • 7
    Fiebiger E, Hammerschmid F, Stingl G, Maurer D. Anti-FcɛRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 1998;101: 243251.
  • 8
    Zuberbier T, Henz BM, Fiebiger E, Maurer D, Stingl G. Anti-FcɛRIalpha serum autoantibodies in different subtypes of urticaria. Allergy 2000;55: 951954.
  • 9
    Sabroe RA, Francis DM, Barr RM, Black AK, Greaves MW. Anti-FcɛRI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 1998;102(4 Pt 1):651658.
  • 10
    Sabroe RA, Seed PT, Francis DM, Barr RM, Black AK, Greaves MW. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcɛRI or anti-IgE autoantibodies. J Am Acad Dermatol 1999;40: 443450.
  • 11
    Toubi E, Kessel A, Avshovich N, Bamberger E, Sabo E, Nusem D et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy 2004;59: 869873.
  • 12
    Sabroe RA, Fiebiger E, Francis DM, Maurer D, Seed PT, Grattan CE et al. Classification of anti-FcɛRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002;110: 492499.
  • 13
    Fagiolo U, Kricek F, Ruf C, Peserico A, Amadori A, Cancian M. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 2000;106: 567572.
  • 14
    Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza BA, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999;140: 446452.
  • 15
    Brunetti L, Francavilla R, Miniello VL, Platzer MH, Rizzi D, Lospalluti ML et al. High prevalence of autoimmune urticaria in children with chronic urticaria. J Allergy Clin Immunol 2004;114: 922927.
  • 16
    Skov PS, Mosbech H, Norn S, Weeke B. Sensitive glass microfibre-based histamine analysis for allergy testing in washed blood cells. Results compared with conventional leukocyte histamine release assay. Allergy 1985;40: 213218.
  • 17
    Pachlopnik JM, Horn MP, Fux M, Dahinden M, Mandallaz M, Schneeberger D et al. Natural anti-FcɛRIalpha autoantibodies may interfere with diagnostic tests for autoimmune urticaria. J Autoimmun 2004;22: 4351.
  • 18
    Tedeschi A, Salmaso C, Di Donato M, Lorini M, Miadonna A. Granulocyte-macrophage colony-stimulating factor and interleukin-3 cause basophil histamine release by a common pathway: downregulation by sodium. Immunology 1999;96: 164170.